Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Milpied

Showing results (121-130 of 240) with videos related to

Pageof 24
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 1991
Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host diseaseA M Stoppa, D Maraninchi, D Blaise, et al.
Leukemia & Lymphoma|December 1, 1993
Early intensive therapy with autotransplantation for high-risk Hodgkin's diseaseP Moreau, N Milpied, F Mechinaud-Lacroix, et al.
Transplantation|November 15, 1995
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III studyJ Y Cahn, P Bordigoni, P Tiberghien, et al.
Bone Marrow Transplantation|April 1, 1993
Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMTC Belanger, H Esperou-Bourdeau, P Bordigoni, et al.
Leukemia & Lymphoma|June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphomaG Cartron, L Voillat, B Desablens, et al.
Leukemia|June 22, 2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized studyM Hunault-Berger, N Milpied, M Bernard, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1995
Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? SFGM. Société Française de Greffe de MoelleM Resbeut, D Cowen, D Blaise, et al.
Leukemia|June 2, 2007
EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemiaT Leguay, C Foucaud, M Parrens, et al.
Lancet (London, England)|March 19, 1994
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantationC Gisselbrecht, H G Prentice, A Bacigalupo, et al.
Cancer|December 1, 1993
Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resectionP Moreau, J R Zahar, N Milpied, et al.
Pageof 24

Showing results (121-130 of 240) with videos related to

Sort By:
Pageof 24
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 1991
Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host diseaseA M Stoppa, D Maraninchi, D Blaise, et al.
Leukemia & Lymphoma|December 1, 1993
Early intensive therapy with autotransplantation for high-risk Hodgkin's diseaseP Moreau, N Milpied, F Mechinaud-Lacroix, et al.
Transplantation|November 15, 1995
Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III studyJ Y Cahn, P Bordigoni, P Tiberghien, et al.
Bone Marrow Transplantation|April 1, 1993
Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMTC Belanger, H Esperou-Bourdeau, P Bordigoni, et al.
Leukemia & Lymphoma|June 28, 2001
Continuous infusion of vincristine-doxorubicin with bolus of dexamethasone(VAD) alternated with CHEP in the treatment of patients over 60 years old with aggressive non-Hodgkin's lymphomaG Cartron, L Voillat, B Desablens, et al.
Leukemia|June 22, 2001
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized studyM Hunault-Berger, N Milpied, M Bernard, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1995
Fractionated or single-dose total body irradiation in 171 acute myeloblastic leukemias in first complete remission: is there a best choice? SFGM. Société Française de Greffe de MoelleM Resbeut, D Cowen, D Blaise, et al.
Leukemia|June 2, 2007
EBV-positive lymphoproliferative disease with medullary, splenic and hepatic infiltration after imatinib mesylate therapy for chronic myeloid leukemiaT Leguay, C Foucaud, M Parrens, et al.
Lancet (London, England)|March 19, 1994
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantationC Gisselbrecht, H G Prentice, A Bacigalupo, et al.
Cancer|December 1, 1993
Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resectionP Moreau, J R Zahar, N Milpied, et al.
Pageof 24